Viewing Study NCT07262567


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2025-12-25 @ 10:46 PM
Study NCT ID: NCT07262567
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-11-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
Sponsor: Genfleet Therapeutics (Shanghai) Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module